Nucleus RadioPharma
Series A in 2023
Nucleus RadioPharma is a company focused on enhancing access to innovative radiopharmaceuticals for cancer patients. It is dedicated to developing technologies that modernize the clinical development, manufacturing, and supply chain processes associated with these therapies. By specializing in novel treatments and technologies, Nucleus RadioPharma aims to improve the diagnosis and treatment of various cancers, ensuring that healthcare professionals can effectively utilize these advanced medical solutions.
Vestagen
Venture Round in 2017
Vestagen Technical Textiles, founded in 2009 and based in Orlando, Florida, specializes in developing, manufacturing, and marketing innovative textile products and technologies. The company holds exclusive North American rights to patented Swiss technologies for medical textiles, allowing for versatile applications ranging from medical uniforms to athletic apparel. Vestagen's primary focus is on addressing critical needs within the healthcare industry, particularly through its proprietary VESTEX Active Barrier fabric. This advanced material is designed to protect healthcare workers and patients by minimizing the risks associated with fluid exposure and reducing the retention of harmful microorganisms on clothing.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.